After receiving tentative approval earlier this summer, Teva Pharmaceutical Industries announced last week that it has won final approval for its generic version of Novartis’ antiviral Famvir.
Teva had said it expected to receive final approval upon the expiration of the mandatory stay of approval associated with generic Famvir (famciclovir) patent litigation...read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment